Alnylam Pharmaceuticals and Isis Pharmaceuticals Sue Tekmira Pharmaceuticals
- January 20, 2012
Alnylam Pharmaceuticals and Isis Pharmaceuticals filed suit against Tekmira Pharmaceuticals over six patents related to encapsulating compounds in lipid bilayers. 1/17, District of Massachusetts, 1:2012cv10087.
Access to the full article is currently available to RPX members only. Please contact us if you need further information.